Pages that link to "Q79909161"
Jump to navigation
Jump to search
The following pages link to Prospective phase II trial of extended treatment with rituximab in patients with B-cell post-transplant lymphoproliferative disease (Q79909161):
Displaying 27 items.
- Posttransplant lymphoproliferative disorders following liver transplantation: Where are we now? (Q26780262) (← links)
- Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report (Q30411688) (← links)
- Therapeutic options in post-transplant lymphoproliferative disorders (Q30455714) (← links)
- Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era. (Q33710720) (← links)
- Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8 (Q35082545) (← links)
- A case series of primary central nervous system posttransplantation lymphoproliferative disorder: imaging and clinical characteristics (Q35639567) (← links)
- Chemoimmunotherapy and withdrawal of immunosuppression for monomorphic posttransplant lymphoproliferative disorders (Q37355856) (← links)
- Post-transplant lymphoproliferative disorder after liver transplantation: Incidence, long-term survival and impact of serum tacrolimus level. (Q37662629) (← links)
- Treatment of post-transplantation lymphoproliferative disorders after kidney transplant with rituximab and conversion to m-TOR inhibitor (Q37679263) (← links)
- Fcγ-receptor IIIA polymorphism p.158F has no negative predictive impact on rituximab therapy with and without sequential chemotherapy in CD20-positive posttransplant lymphoproliferative disorder. (Q37704588) (← links)
- Post‐transplant lymphoproliferative disorders in lung transplant recipients: 20‐yr experience at the University of Minnesota (Q37809559) (← links)
- Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations. (Q37975458) (← links)
- Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies (Q38112050) (← links)
- Infectious complications of immune modulatory agents. (Q38144976) (← links)
- Treatment Response and Outcomes in Post-transplantation Lymphoproliferative Disease vs Lymphoma in Immunocompetent Patients (Q39445421) (← links)
- The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder (Q41219311) (← links)
- Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial. (Q42628866) (← links)
- Impact of the posttransplant lymphoproliferative disorder subtype on survival. (Q51734713) (← links)
- Three Severe Cases of Viral Infections with Post-Kidney Transplantation Successfully Confirmed by Polymerase Chain Reaction and Flow Cytometry (Q58551146) (← links)
- Spanish Lymphoma Group (GELTAMO) guidelines for the diagnosis, staging, treatment, and follow-up of diffuse large B-cell lymphoma (Q58767936) (← links)
- High-dose intravenous rituximab for multifocal, monomorphic primary central nervous system posttransplant lymphoproliferative disorder (Q85096591) (← links)
- Post-transplant lymphoproliferative disorders (Q86673165) (← links)
- Management of Non-Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder (Q88802166) (← links)
- Post-transplant lymphoproliferative disorders (Q89217688) (← links)
- Post-transplantation lymphoproliferative disorders: Current concepts and future therapeutic approaches (Q90748114) (← links)
- Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: a comprehensive review from pathogenesis to forthcoming treatment modalities (Q92023502) (← links)
- Post-transplant lymphoproliferative disorder of the cauda equina in a kidney transplant recipient (Q92989822) (← links)